Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)Symptoms, Doctors, Treatments, Advances & More
Learn About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
MUSC Health ENT - Ben Sawyer
Rodney Schlosser is an Otolaryngologist practicing medicine in Mount Pleasant, South Carolina. Dr. Schlosser is rated as an Elite provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Septoplasty, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Schlosser is currently accepting new patients.
Northwestern Memorial Hospital
Kevin Welch practices practicing medicine in Chicago, Illinois. Dr. Welch is rated as an Elite provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Sinusitis, Septoplasty, and Endoscopy. Dr. Welch is board certified in Board Certification: Otolaryngology, American Board Of Otolaryngology-Head And Neck Surgery.
MUSC Health ENT At Rutledge Tower
Zachary Soler is an Otolaryngologist practicing medicine in Charleston, South Carolina. Dr. Soler is rated as an Elite provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Nasal Polyps, Septoplasty, and Endoscopy. Dr. Soler is currently accepting new patients.
Summary: The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
Summary: This study will evaluate the efficacy and safety of depemokimab (GSK3511294) without concomitant use of Intranasal corticosteroids (INCS) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).